The News story on gene-therapy trials in severe combined immundeficiency disease (Nature 419, 660; 2002) incorrectly stated that the US Food and Drug Administration (FDA) had decided that the trials should continue. In fact, an advisory committee to the FDA recommended that the trials be permitted to resume, but the FDA has not yet lifted their suspension.
Additional information
The online version of the original article can be found at 10.1038/419660a
Rights and permissions
About this article
Cite this article
Correction. Nature 419, 771 (2002). https://doi.org/10.1038/419771a
Issue Date:
DOI: https://doi.org/10.1038/419771a
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
